Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study.
JAMA. 2005 Sep 14;294(10):1224-32. doi: 10.1001/jama.294.10.1224. Epub 2005 Sep 4.
JAMA. 2005.
PMID: 16143698
Clinical Trial.
OBJECTIVE: To determine if clopidogrel pretreatment before PCI in patients with recent ST-segment elevation myocardial infarction (STEMI) is superior to clopidogrel treatment initiated at the time of PCI in preventing major adverse cardiovascular event …
OBJECTIVE: To determine if clopidogrel pretreatment before PCI in patients with recent ST-segment elevation myocardial infa …
Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
Sabatine MS, Morrow DA, Montalescot G, Dellborg M, Leiva-Pons JL, Keltai M, Murphy SA, McCabe CH, Gibson CM, Cannon CP, Antman EM, Braunwald E; Clopidogrel as Adjunctive Reperfusion Therapy (CLARITY)-Thrombolysis in Myocardial Infarction (TIMI) 28 Investigators.
Sabatine MS, et al.
Circulation. 2005 Dec 20;112(25):3846-54. doi: 10.1161/CIRCULATIONAHA.105.595397. Epub 2005 Nov 15.
Circulation. 2005.
PMID: 16291601
Clinical Trial.
Whether these advantages translate into greater infarct-related artery patency and fewer adverse clinical events in patients with ST-elevation myocardial infarction (STEMI) receiving fibrinolytic therapy remains under study. ...Patients who received both c …
Whether these advantages translate into greater infarct-related artery patency and fewer adverse clinical events in patients with ST-elevati …
Item in Clipboard
Cite
Cite